Six years ago Abiraterone was hailed as a medical breakthrough that could offer men extra time with loved ones and a chance to delay chemotherapy and its debilitating side effects.
Today the body that recommends what can and cannot be paid for said it 'wasn't cost effective'.
Prostate cancer patients have now been told that the life-extending drug will not be routinely prescribed unless they have chemotherapy.
One man from North Yorkshire who is fighting prostate cancer is calling for a rethink:
More top news
PM announces funding will be made available for a memorial dedicated to the victims of last week’s terrorist attack in Tunisia
Leah Washington, 17, had to have her left leg amputated after being trapped for hours on The Smiler rollercoaster at the theme park.
Helen Plint has the evening forecast